메뉴 건너뛰기




Volumn 127, Issue 5, 2014, Pages 779-780

The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset

Author keywords

[No Author keywords available]

Indexed keywords

3 (1,3 BENZODIOXOL 5 YL) 5 (3 BROMOPHENYL) 1H PYRAZOLE; ANLE 138B; ANTIPARKINSON AGENT; OLIGOMER; UNCLASSIFIED DRUG; 1,3 BENZODIOXOLE DERIVATIVE; 3-(1,3-BENZODIOXOL-5-YL)-5-(3-BROMOPHENYL)-1H-PYRAZOLE; ALPHA SYNUCLEIN; PYRAZOLE DERIVATIVE; SNCA PROTEIN, HUMAN;

EID: 84899969800     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-014-1265-3     Document Type: Letter
Times cited : (104)

References (5)
  • 1
    • 79955671043 scopus 로고    scopus 로고
    • Targeting oligomers in neurodegenerative disorders: Lessons from α-synuclein, tau, and amyloid-β peptide
    • Gadad BS, Britton GB, Rao KS (2011) Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide. J Alzheimers Dis 24(Suppl 2):223-232
    • (2011) J Alzheimers Dis , vol.24 , Issue.SUPPL. 2 , pp. 223-232
    • Gadad, B.S.1    Britton, G.B.2    Rao, K.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.